Nisa Investment Advisors LLC Sells 17,138 Shares of Corteva, Inc. $CTVA

Nisa Investment Advisors LLC trimmed its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 7.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 228,953 shares of the company’s stock after selling 17,138 shares during the period. Nisa Investment Advisors LLC’s holdings in Corteva were worth $15,347,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in CTVA. Activest Wealth Management boosted its holdings in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC bought a new position in shares of Corteva during the third quarter valued at $25,000. True Wealth Design LLC increased its holdings in shares of Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after acquiring an additional 264 shares in the last quarter. Total Investment Management Inc. purchased a new position in shares of Corteva in the 2nd quarter worth about $27,000. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Corteva in the 2nd quarter worth about $29,000. 81.54% of the stock is owned by institutional investors.

Corteva Price Performance

CTVA opened at $83.99 on Thursday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock has a market capitalization of $56.39 billion, a P/E ratio of 53.16, a P/E/G ratio of 2.86 and a beta of 0.72. The company’s 50-day simple moving average is $77.07 and its two-hundred day simple moving average is $69.88. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $84.14.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were paid a dividend of $0.18 per share. The ex-dividend date was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Insiders Place Their Bets

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.14% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on CTVA. Jefferies Financial Group increased their price objective on shares of Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. BNP Paribas Exane upped their target price on shares of Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Royal Bank Of Canada boosted their price objective on shares of Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Bank of America upped their price objective on Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $83.19.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.